Search Protocols under revision. Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapySolid TumorsProtocol groupTransplantationUrologic OncologyDiseaseTesticular TumorSubgroupICD10C62.-MeSHNeoplasms, Germ Cell and EmbryonalTesticular NeoplasmsSequenceChemotherapyChemo-substanceCarboplatinEtoposideChemo-substanceCarboplatinEtoposideChemo-substanceCarboplatinEtoposideChemo-substanceCarboplatinEtoposideNo. Substances2 RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleDexamethasoneFosaprepitantGranisetronValaciclovirSupportive substanceBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleDexamethasoneFosaprepitantGranisetronValaciclovirSupportive substanceBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleDexamethasoneFosaprepitantGranisetronValaciclovirSupportive substanceBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleDexamethasoneFosaprepitantGranisetronValaciclovirNo. Substances7Protocol classificationTherapy classificationcurrent standardIntensityHochdosis, bei autologer SZTTherapy indicationRelapse therapyTherapy phaseautologous stem cell transplantationTherapy intentioncurativeRisksBleedingCardiotoxicityDyspneaEmetogenicity (MASCC/ESMO)Febrile NeutropeniaHepatotoxicityInfectionsNeurotoxicityRenal Failure only studiesPublicationAuthorLorch ADiseaseHodenkarzinom, rezidiviert oder therapierefraktär, ECOG 0-2, Kreatinin-Clearance mind. 70 ml/minOriginDepartment of Hematology, Universitätsklinikum Giessen und Marburg GmbH, Marburg, GermanyProtokolle in Überarbeitung 1 protocol foundCE (Carboplatin 500 / Etoposide 500), Testicular Carcinoma, Autologous Stem Cell Transplantation (PID1574 V1.1)
